Free Trial

Pro-Dex (NASDAQ:PDEX) Stock Price Crosses Above Two Hundred Day Moving Average - What's Next?

Pro-Dex logo with Medical background

Key Points

  • Pro-Dex's stock price surpassed its 200-day moving average of $45.79, reaching a high of $48.64 during trading, before closing at $45.71.
  • Analyst ratings for Pro-Dex have improved, with Ascendiant Capital Markets raising its price target from $54.00 to $56.00 and upgrading the stock to a "buy" rating.
  • Institutional investors have increased their stakes in Pro-Dex, with notable increases from Acadian Asset Management and Northern Trust Corp, reflecting growing confidence in the company.
  • Looking to export and analyze Pro-Dex data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report)'s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $45.79 and traded as high as $48.64. Pro-Dex shares last traded at $45.71, with a volume of 57,239 shares trading hands.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Wall Street Zen raised shares of Pro-Dex from a "hold" rating to a "buy" rating in a report on Tuesday, May 13th. Ascendiant Capital Markets upped their target price on shares of Pro-Dex from $54.00 to $56.00 and gave the company a "buy" rating in a report on Tuesday, May 27th.

Get Our Latest Report on PDEX

Pro-Dex Trading Up 2.6%

The company has a debt-to-equity ratio of 0.28, a current ratio of 2.73 and a quick ratio of 1.45. The business's 50 day moving average price is $45.15 and its 200-day moving average price is $45.84. The firm has a market capitalization of $155.67 million, a price-to-earnings ratio of 17.05 and a beta of 0.19.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Police & Firemen s Retirement System of New Jersey purchased a new position in Pro-Dex in the second quarter valued at about $28,000. Cubist Systematic Strategies LLC purchased a new position in Pro-Dex in the first quarter valued at about $170,000. Morgan Dempsey Capital Management LLC purchased a new position in Pro-Dex in the second quarter valued at about $179,000. Trexquant Investment LP purchased a new position in Pro-Dex in the fourth quarter valued at about $252,000. Finally, Arrowstreet Capital Limited Partnership purchased a new position in Pro-Dex in the fourth quarter valued at about $255,000. 15.28% of the stock is currently owned by institutional investors and hedge funds.

About Pro-Dex

(Get Free Report)

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.

Further Reading

Should You Invest $1,000 in Pro-Dex Right Now?

Before you consider Pro-Dex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pro-Dex wasn't on the list.

While Pro-Dex currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines